A Phase I Trial of CCT303-406 in Patients With Relapsed or Refractory HER2 Positive Solid Tumors
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Solid Tumor|Gastric Cancer|Breast Cancer|Ovarian Cancer|Sarcoma
Interventions: BIOLOGICAL: CCT303-406
Sponsor: Shanghai PerHum Therapeutics Co., Ltd.
Collaborators: Shanghai Zhongshan Hospital